Engineering mouse chromosomes with Cre-loxP: range, efficiency, and somatic applications.

Area of Science:

• Genetics
• Genomics
• Molecular Biology

Background:

• Chromosomal rearrangements are crucial tools for genetic studies.
• Cre-loxP based chromosome engineering enables the introduction of defined rearrangements into the mouse genome.
• Systematic evaluation of this technology's limits is necessary.

Purpose of the Study:

• To systematically evaluate the efficiency and limits of Cre-loxP based chromosome engineering on mouse chromosome 11.
• To determine the feasibility of constructing large chromosomal rearrangements using this method.
• To assess the potential applications of in vivo chromosome engineering.

Main Methods:

• Utilizing Cre-loxP recombination to introduce deletions, duplications, and inversions.
• Applying the technology to mouse chromosome 11.
• Evaluating recombination efficiency across varying genetic distances.
• Assessing viability of engineered embryonic stem (ES) cells.

Main Results:

• Cre-loxP mediated recombination efficiency remains high even for rearrangements spanning large genetic distances on the same chromosome.
• Rearrangements involving up to 75% of mouse chromosome 11 were successfully constructed in ES cells.
• Smaller deletions were efficiently produced in both ES cells and in vivo in a tissue-specific manner.
• Larger deletions were found to be potentially lethal to ES cells.

Conclusions:

• The Cre-loxP strategy is capable of generating virtually any chromosomal rearrangement in ES cells, provided it does not compromise cell viability.
• In vivo chromosome engineering holds promise for creating mouse models of human cancers through somatic loss of heterozygosity.
• This technology expands the toolkit for genetic studies and disease modeling.